All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their ...

The extension, released shortly before the flexibilities were set to expire at the end of 2025, gives regulators more time to ...

The extension allows providers to continue remotely prescribing Schedule II–V controlled substances under specific conditions to prevent a disruptive "telemedicine cliff." ...

Get inspired by a weekly roundup on living well, made simple. Sign up for CNN’s Life, But Better newsletter for information and tools designed to improve your well-being. As the pandemic public health ...

The American Telemedicine Association announced that the U.S. Drug Enforcement Administration, or DEA, granted a 1-year extension for remote prescribing of controlled medications just before the ...